JPMorgan Chase & Co’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1 | Hold |
23
| – | – | ﹤0.01% | 6126 |
|
|
2025
Q1 | $1 | Hold |
23
| – | – | ﹤0.01% | 6385 |
|
|
2024
Q4 | $1 | Hold |
23
| – | – | ﹤0.01% | 6303 |
|
|
2024
Q3 | $1 | Hold |
23
| – | – | ﹤0.01% | 6296 |
|
|
2024
Q2 | $1 | Hold |
23
| – | – | ﹤0.01% | 6256 |
|
|
2024
Q1 | $1 | Hold |
23
| – | – | ﹤0.01% | 6312 |
|
|
2023
Q4 | $2 | Buy |
+23
| New | +$2 | ﹤0.01% | 6428 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3314 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3411 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3438 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3396 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3408 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3489 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3629 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3879 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3826 |
|